Striatal CaV1.3'ün genetik olarak susturulması levodopa diskineziyi önler ve ortadan kaldırır.
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia.
DOI: 10.1002/mds.27695PMID: 31002755
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia.
DOI: 10.1002/mds.27695PMID: 31002755
Evaluating the Potential of <i>Portulaca oleracea</i> L. for Parkinson's Disease Treatment Using a <i>Drosophila</i> Model with <i>dUCH</i>-Knockdown.
DOI: 10.1155/2019/1818259PMID: 31143437
Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
DOI: 10.1016/j.brainresbull.2019.04.012PMID: 31004735
Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan.
DOI: 10.3389/fneur.2019.00340PMID: 31040814
Cell therapy for Parkinson's disease is coming of age: current challenges and future prospects with a focus on immunomodulation.
DOI: 10.1038/s41434-019-0077-4PMID: 30992523
Prominent Oromandibular Dystonia as Levodopa-induced Dyskinesia in Idiopathic Parkinson's Disease.
DOI: 10.1002/mdc3.12759PMID: 31061844
Depression in neurodegenerative diseases: Common mechanisms and current treatment options.
DOI: 10.1016/j.neubiorev.2019.04.002PMID: 30995512
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
DOI: 10.1002/mds.27691PMID: 30983023
Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
DOI: 10.1016/j.neulet.2019.04.029PMID: 30995519
Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
DOI: 10.1080/15548627.2019.1603545PMID: 30983487
Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
DOI: 10.1016/j.ejmech.2019.04.016PMID: 31005056
Garcinol, a multifaceted sword for the treatment of Parkinson's disease.
DOI: 10.1016/j.neuint.2019.04.004PMID: 30986504
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.